Anti-VEGF therapy is not linked to an increased risk of stroke, myocardial infarction or death, according to a new report.
Read MoreAnti-VEGF therapy is not linked to an increased risk of stroke, myocardial infarction or death, according to a new report.
Read MoreScientists have found three new genes associated with age-related macular degeneration (AMD).
Read MoreUp to a quarter of anti-VEGF patients being treated for AMD and diabetic macular oedema are lost to follow-up.
Read MoreAn electronic retinal implant to treat age-related macular degeneration, has shown excellent results in a small clinical trial.
Read MoreA report and new digital training tools aim to improve understanding of eye health and vision loss in Australia’s residential aged care facilities.
Read MoreA change to the Pharmaceutical Benefits Scheme listing for two key medicines, is a “big win for the macular disease community”.
Read MoreThe impact of vision loss due to AMD on patients’ quality of life and psychological well-being is comparable to that of cancer or coronary heart disease.
Read MoreAfter the initial shock of diagnosis, Val realised she needed to accept that age-related macular degeneration is part of her life.
Read More